Skip to content
Baltimore News Journal – Lifestyle
Author:
Cytonics Corporation
/C O R R E C T I O N – Cytonics Corporation/
November 19, 2026
Cytonics Uses Ten Years of Osteoarthritis Natural-History Data to Shape the Next Stage of CYT-108 Clinical Development
November 18, 2026
Cytonics Completes $4.8 Million Gross-Proceeds Financing Campaign
September 9, 2026
Cytonics Completes First-In-Human Phase 1 Clinical Study Report for CYT-108, Advancing Program Toward Next Phase of Development.
June 30, 2026